chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.2
Sex: U
Vaccine: FLUX
Symptoms: Autopsy, Death
Clinical narrative: We received the following literature report: In 2002 with the documentation of a sizeable burden of influenza in children 6-23 months of age, the committee "encouraged" children in this age group to receive TIV. To assess TIV vaccine safety, the committee and co-workers analyzed all of the adverse events (AE) reported to the Vaccine Adverse Event Reporting System (VAERS) after TIV in children less than 2 years of age between 1990 and June 2003. There were 15 reported deaths with the majority occurring in previously healthy children. Most had an autopsy to assess the cause of death. A single case of myocarditis was reported and cannot be definitively linked to influenza vaccination. Although myocarditis and dilated cardiomyopathy have been reported following smallpox vaccination, the pathologic findings reported in those cases differ from this case and TIV is an inactivated, not a live vaccine. The classification of 6 deaths as possibly related to TIV primarily reflects limitations of the individual case reports and causality assessment methods. Among the 15 fatalities, 6 were possibly related, 7 unlikely related, and 2 unrelated to TIV vaccination (please refer also to cases MA2009-1438 to MA2009-1443, MA2009-1445, MA2009-1447 to MA2009-1448 and MA2009-1450 to MA2009-1454). This case refers to a 14-month-old patient who was found dead in a crib two days after influenza vaccination (batch no. and manufacturer unknown). Autopsy results: Death ruled undetermined, pathology with chronic bronchitis, sick contact with parainfluenza.
Age: 1.1
Sex: U
Vaccine: FLUX, HIBV, MMR, VARCEL
Symptoms: Apnoea, Autopsy, Death, Respiratory disorder
Clinical narrative: We received the following literature report: In 2002 with the documentation of the sizeable burden of influenza in children 6-23 months of age, the committee "encouraged" children in this age group to received trivalent influenza vaccination (TIV). To assess TIV vaccine safety, co-workers analyzed all of the adverse events (AE) reported to the Vaccine Adverse Event Reporting System (VAERS) after TIV in children less than 2 years of age between 1990 and June 2003. There were 15 reported deaths with the majority occurring in previously healthy children. Most had an autopsy to assess cause of death. A single case of myocarditis was reported and cannot be definitively linked to influenza vaccination. Although myocarditis and dilated cardiomyopathy have been reported following smallpox vaccination, the pathologic findings reported in those cases differ from this case and TIV is an inactivated, not a live vaccine. The classification of 6 deaths as possibly related to TIV primarily reflects limitations of the individual case reports and causality assessment methods. Among the 15 fatalities, 6 were possibly related, 7 unlikely related, and 2 unrelated to TIV vaccination (please refer also to cases MA2009-1438 to MA2009-1443, MA2009-1445, MA2009-1447 to MA2008-1449 and MA2009-1451 to MA2009-1454). This case refers to a 13-month-old patient who developed upper respiratory symptoms that lead to apnea and death one day after influenza vaccination (batch no. and manufacturer unknown). Autopsy results: not provided. Vaccines received with TIV: HIB/Varicella/MMR.
Age: 1.1
Sex: U
Vaccine: FLUX, HEP, PPV
Symptoms: Autopsy, Cardiac failure, Death, Myocarditis
Clinical narrative: We received the following literature report: In 2002 with the documentation of a sizeable burden of influenza in children 6-23 months of age, the committee "encouraged" children in this age group to receive TIV. To assess TIV vaccine safety, the committee and co-workers analyzed all of the adverse events (AE) reported to the Vaccine Adverse Event Reporting System (VAERS) after TIV in children less than 2 years of age between 1990 and June 2003. There were 15 reported deaths with the majority occurring in previously healthy children. Most had an autopsy to assess the cause of death. A single case of myocarditis was reported and cannot be definitively linked to influenza vaccination. Although myocarditis and dilated cardiomyopathy have been reported following smallpox vaccination, the pathologic findings reported in those cases differ from this case and TIV is an inactivated, not a live vaccine. The classification of 6 deaths as possibly related to TIV primarily reflects limitations of the individual case reports and causality assessment methods. Among the 15 fatalities, 6 were possibly related, 7 unlikely related, and 2 unrelated to TIV vaccination (please refer also to cases MA2009-1438 to MA2009-1442, MA2009-1445 and MA2009-1447 to MA2009-1454). This case refers to a 13-month-old patient who developed heart failure seven days after influenza vaccination (batch no. and manufacturer unknown). Vaccines received with TIV: HIB/PCV. Autopsy results: myocarditis.
Age: 1.6
Sex: U
Vaccine: FLUX
Symptoms: Autopsy, Death
Clinical narrative: We received the following literature report: In 2002 with the documentation of the sizeable burden of influenza in children 6-23 months of age, the Advisory Committee "encouraged" children in this age group to receive trivalent influenza vaccination (TIV). To assess TIV vaccine safety, author and co-workers analyzed all of the adverse events (AE) reported to the Vaccine Adverse Event Reporting System (VAERS) after TIV in children less than 2 years of age between 1990 and June 2003. There were 15 reported deaths with the majority occurring in previously healthy children. Most had an autopsy to assess cause of death. A single case of myocarditis was reported and cannot be definitively linked to influenza vaccination. Although myocarditis and dilated cardiomyopathy have been reported following smallpox vaccination, the pathological findings reported in those cases differ from this case and TIV is an inactivated, not a live vaccine. The classification of 6 deaths as possibly related to TIV primarily reflects limitations of the individual case reports and causality assessment methods. Among the 15 fatalities, 6 were possibly related, 7 unlikely related, and 2 unrelated to TIV vaccination (please refer to cases MA2009-1438 to MA2009-1443, MA2009-1445, MA2009-1447 to MA2009-1450 and MA2009-1452 to MA2009-1454). This case refers to a 19-month-old patient who was found dead in crib one day after influenza vaccination (batch no. and manufacturer unknown). Medical history: bronchitis 10 days prior to vaccination. Autopsy results: none available.
Age: 1.0
Sex: U
Vaccine: FLUX, MMR, VARCEL
Symptoms: Autopsy, Death, Irritability, Pyrexia, Respiratory disorder
Clinical narrative: We received the following literature report: In 2002 with the documentation of the sizeable burden of influenza in children 6-23 months of age, the committee "encouraged" children in this age group to received trivalent influenza vaccination (TIV). To assess TIV vaccine safety, co-workers analyzed all of the adverse events (AE) reported to the Vaccine Adverse Event Reporting System (VAERS) after TIV in children less than 2 years of age between 1990 and June 2003. There were 15 reported deaths with the majority occurring in previously healthy children. Most had an autopsy to assess cause of death. A single case of myocarditis was reported and cannot be definitively linked to influenza vaccination. Although myocarditis and dilated cardiomyopathy have been reported following small pox vaccination, the pathologic findings reported in those cases differ from this case and TIV is an inactivated, not a live vaccine. The classification of 6 deaths as possibly related to TIV primarily reflects limitations of the individual case reports and causality assessment methods. Among the 15 fatalities, 6 were possibly related, 7 unlikely related, and 2 unrelated to TIV vaccination (please refer also to cases MA2009-1438 to MA2009-1443, MA2009-1445, MA2009-1447 to MA2009-1452 and MA2009-1454). This case refers to a 12-month-old patient who developed mild upper respiratory symptoms, fever and fussy five days after influenza vaccination (batch no. and manufacturer unknown) and died (unexpected). Vaccines received with TIV: Varicella/MMR. Autopsy results: natural causes.
Age: 1.9
Sex: U
Vaccine: FLUX
Symptoms: Autopsy, Brain oedema, Culture negative, Death, Encephalopathy
Clinical narrative: We received the following literature report: In 2002 with the documentation of the sizeable burden of influenza in children 6-23 months of age, the committee "encouraged" children in this age group to received trivalent influenza vaccination (TIV). To assess TIV vaccine safety, co-workers analyzed all of the adverse events (AE) reported to the Vaccine Adverse Event Reporting System (VAERS) after TIV in children less than 2 years of age between 1990 and June 2003. There were 15 reported deaths with the majority occurring in previously healthy children. Most had an autopsy to assess cause of death. A single case of myocarditis was reported and cannot be definitively linked to influenza vaccination. Although myocarditis and dilated cardiomyopathy have been reported following smallpox vaccination, the pathologic findings reported in those cases differ from this case and TIV is an inactivated, not a live vaccine. The classification of 6 deaths as possibly related to TIV primary reflects limitations of the individual case reports and causality assessment methods. Among the 15 fatalities, 6 were possibly related, 7 unlikely related, and 2 unrelated to TIV vaccination (please refer also to cases MA2009-1438 to MA2009-1443, MA2009-1445 and MA2009-1447 to MA2009-1453). This case refers to a 23-month-old patient who developed low-grade fever, cranky, gastrointestinal illness, and ulcers on lower lip seven days after influenza vaccination (batch no. and manufacturer unknown). The patient died one week after vaccination. Autopsy results: complications from viral infections. Cultures negative. Pathology of brain: focal perivascular chronic inflammation combined with viral encephalopathy/brain edema. Lung pathology: minimal edema and minimal acute and chronic inflammation.
Age: 1.9
Sex: U
Vaccine: FLUX
Symptoms: Gastrointestinal disorder, Irritability, Lip ulceration, Pathology test, Pyrexia
Clinical narrative: We received the following literature report: In 2002 with the documentation of the sizeable burden of influenza in children 6-23 months of age, the committee "encouraged" children in this age group to received trivalent influenza vaccination (TIV). To assess TIV vaccine safety, co-workers analyzed all of the adverse events (AE) reported to the Vaccine Adverse Event Reporting System (VAERS) after TIV in children less than 2 years of age between 1990 and June 2003. There were 15 reported deaths with the majority occurring in previously healthy children. Most had an autopsy to assess cause of death. A single case of myocarditis was reported and cannot be definitively linked to influenza vaccination. Although myocarditis and dilated cardiomyopathy have been reported following smallpox vaccination, the pathologic findings reported in those cases differ from this case and TIV is an inactivated, not a live vaccine. The classification of 6 deaths as possibly related to TIV primary reflects limitations of the individual case reports and causality assessment methods. Among the 15 fatalities, 6 were possibly related, 7 unlikely related, and 2 unrelated to TIV vaccination (please refer also to cases MA2009-1438 to MA2009-1443, MA2009-1445 and MA2009-1447 to MA2009-1453). This case refers to a 23-month-old patient who developed low-grade fever, cranky, gastrointestinal illness, and ulcers on lower lip seven days after influenza vaccination (batch no. and manufacturer unknown). The patient died one week after vaccination. Autopsy results: complications from viral infections. Cultures negative. Pathology of brain: focal perivascular chronic inflammation combined with viral encephalopathy/brain edema. Lung pathology: minimal edema and minimal acute and chronic inflammation.
Age: 51.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, Rash, Rubella antibody negative, Vaccination failure
Clinical narrative: Information has been received from a registered nurse (RN) concerning an approximately 52 year old female with  no pertinent medical history who on 24-APR-2007 was vaccinated SQ with a 0.5 ml dose of MMR II (HSA) (lot # 653335/0215F). There was no concomitant medication. Approximately 12 days post MMR II (06-MAY-2007) the patient experienced rash on abdominal area. In Approximately 2008 the RN reports that the patient had a vaccine failure with MMR II, the titer came back as negative. The patient sought medical attention and was seen by a nurse. At the time of the report it was reported that the patient has no symptoms. A product quality complaint was not involved. Additional information has been requested. The rash was reported to VAERS 18-MAY-2007.
Age: 1.0
Sex: M
Vaccine: DTAPHEPBIP, MMR, VARCEL, DTAPHEPBIP, HIBV, MMR, VARCEL
Symptoms: Dyspnoea, Generalised erythema, Livedo reticularis
Clinical narrative: Information has been received concerning a 12 month old white with dilated cardiomyopathy, cough and lung sounds, coarse respiration and a history of cardiac arrest, hypoxic encephalopathy and spastic quadriparesis who on 09-Apr-2008 in the evening was vaccinated SC with his first dose of MMR II (lot# 658164/1672U) in the left arm. Other concomitant vaccinations administered that same day in the evening included the third IM dose of ACTHIB (lot# UF241CA) in the left vastus lateralis and the third IM dose of PEDIARIX (lot# AC21B142AB) in the left vastus lateralis. On 10-April-2008 at 15:00 the skin immediately became mottled then red all over the body on the back, face then extremities. No medical attention was sought. No labs or diagnostic studies were performed. The patient was treated with Benadryl and Tylenol, his G-tube was flushed and the patient was observed. Subsequently, the patient recovered. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: DTAPHEPBIP, MMR, VARCEL, DTAPHEPBIP, HIBV, MMR, VARCEL
Symptoms: Generalised erythema, Immediate post-injection reaction, Livedo reticularis
Clinical narrative: Information has been received concerning a 12 month old white with dilated cardiomyopathy, cough and lung sounds, coarse respiration and a history of cardiac arrest, hypoxic encephalopathy and spastic quadriparesis who on 09-Apr-2008 in the evening was vaccinated SC with his first dose of MMR II (lot# 658164/1672U) in the left arm. Other concomitant vaccinations administered that same day in the evening included the third IM dose of ACTHIB (lot# UF241CA) in the left vastus lateralis and the third IM dose of PEDIARIX (lot# AC21B142AB) in the left vastus lateralis. On 10-April-2008 at 15:00 the skin immediately became mottled then red all over the body on the back, face then extremities. No medical attention was sought. No labs or diagnostic studies were performed. The patient was treated with Benadryl and Tylenol, his G-tube was flushed and the patient was observed. Subsequently, the patient recovered. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Lip swelling, Oedema peripheral, Urticaria
Clinical narrative: Information has been received from a caller concerning her 4 year old daughter with Penicillin allergy and a history of rash after taking Penicillin (manufacturer unknown), and vomiting when she received the Polio vaccine (manufacturer unknown), who on 05-Sep-2008, was vaccinated with MMR II (lot#659878), 0.5ml injection. Concomitant therapy included Claritin and Zyrtec. On 07-Sep-2008, two days after receiving the vaccine, the patient had hives all over her legs, two on her arm, and one on her chin. She currently has hives covering her entire body. Also her right foot is swollen as well as her lip. No laboratory tests were performed. The patient has not recovered from the events. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been received from a physician indicating that the 5 year old female received her first dose of MMR II, SQ in LL on 05-Sep-2008 at 2:30 pm. 2 days after MMR II, rash started and evolved into erythema multiforme. There was no reaction at injection site. The patient has a long history of urticarial reaction at injection site. The patient has a long history of urticarial reactions. At this time, it is unknown if the patient has recovered. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Chest pain, Dyspnoea, Rash, Urticaria, Vomiting
Clinical narrative: Information has been received from a pharmacy student concerning a 4 year old male who on 23-SEP-2008 was vaccinated with MMR II (lot # 661792/0891X) and VARIVAX, and 15 minutes later, he experienced chest pain, vomiting and generalized hives. The child also received INFANRIX/IPV (GSK) at the time well visit. The child was evaluated at the ER and then released. At the time of reporting, it is unknown if the patient recovered. No product quality complaint involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 05/29/2009.  Information has been received from a pharmacy student concerning a 4 year old male who on 23-SEP-2008 was vaccinated with MMR II (lot # 661792/0891X) and VARIVAX, and 15 minutes later, he experienced chest pain, vomiting and generalized hives.  The child also received KINRIX (GSK) at the same well visit.  The child was evaluated at the ER and then released.  At the time of reporting, it is unknown if the patient recovered.  No product quality complaint involved.  Follow up information has been received from a registered nurse concerning a 4 year old white male patient (31 Ib 12 oz, 38 1/2 inch) who on 23-SEP-2008 7:00 pm was vaccinated subcutaneously with the second dose of MMR II (lot # 661792/0891X).  Concomitant therapy included the second dose of VARIVAX, subcutaneously on right thigh, lot # 659737/1783U) on 23-SEP-2008 7:00 PM, the first dose of KINRIX (intramuscular on left thigh, lot # AC20B116AB) on 23-SEP-2008 7:00 PM.  On 23-SEP-2008 7:30 PM the patient developed rash, vomiting and complainted of chest pain and difficulty breathing.  The patient had no illness at the time of vaccination.  On the samday 23-SEP-2008, the patient recovered.  Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a nurse concerning a 12 month old white male patient with no previous medical history or allergies reported who on 06-AUG-2008 was vaccinated with the first dose in the series of MMR II (Lot # 658516/0215X) SQ and VARIVAX (Lot # 660408/0273X).  Concomitantly at the same time, the patient was vaccinated with HAVRIX and PREVNAR.  On 08-AUG-2008, the patient broke out in hives that covered chest back and extremities.  The nurse reported the patient was taken to urgent care and was treated with BENADRYL and was then released the same day.  The patient was given a prescription for BENADRYL and was told to avoid heat for the hives that covered his chest, back and extremities.  Subsequently, on an unspecified date the patient recovered from hives.  No further information is available.
Age: 0.8
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a consumer concerning her healthy 9 and 1/2 month old daughter who on 07-JAN-2009 was vaccinated with a dose of VAQTA instead of Hep B (manufacturer unknown). The patient did not receive any other vaccinations at this appointment. Medical attention was sought in the office. There were no adverse effects reported. At the time of the report, the patient's status was unknown. It was reported that the consumer did not know if product confusion was involved. No further information is available.
Age: 0.8
Sex: F
Vaccine: HEPA, HEPA
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a consumer concerning her healthy 9 and 1/2 month old daughter who on 07-JAN-2009 was vaccinated with a dose of VAQTA instead of Hep B (manufacturer unknown). The patient did not receive any other vaccinations at this appointment. Medical attention was sought in the office. There were no adverse effects reported. At the time of the report, the patient's status was unknown. It was reported that the consumer did not know if product confusion was involved. No further information is available.
Age: 29.0
Sex: F
Vaccine: UNK, TDAP
Symptoms: Body temperature increased, Cellulitis
Clinical narrative: TEMP UP TO GREATER THAN 102 WITHIN 4 HOURS. FATIGUE, NAUSEA. CELLULITIS PICTURE 48 HOURS LATER.                                                                                                                                                LAST TDAP 1999 WITH NO ADVERSE EVENTS, PER PATIENT.
Age: 29.0
Sex: F
Vaccine: UNK, TDAP
Symptoms: Body temperature increased, Cellulitis, Fatigue, Nausea, No reaction on previous exposure to drug
Clinical narrative: TEMP UP TO GREATER THAN 102 WITHIN 4 HOURS. FATIGUE, NAUSEA. CELLULITIS PICTURE 48 HOURS LATER.                                                                                                                                                LAST TDAP 1999 WITH NO ADVERSE EVENTS, PER PATIENT.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: sWELLING AND REDNESS ON RIGHT THIGH,LATERAL ASPECT MEASURING 55cm X 70cm.
Sex: U
Vaccine: VARZOS
Symptoms: Death
Clinical narrative: Information has been received from a registered nurse concerning a patient with a history of coronary artery bypass who on an unspecified date was vaccinated with ZOSTAVAX (Merck) (lot number, route and site not reported) after cardiac bypass surgery and then died. It was unknown if the patient sought medical attention. The patient's death was considered to be disabling. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: DTAP
Symptoms: Convulsion, Vomiting
Clinical narrative: 2 days after had a seizure with vomiting. Date immunization given rash on back and abdomen. No prior fever.  8/26/09 Hospital records received DOS 6/10/09. Assessment: Seizure-like activity, Elevated white count with bandemia, Chronic sinusitis.  Patient was admitted throught the ER after presenting with seizure-like activity while sleeping during the night - stiff, arching, eyes opened and glazed, not responsive. Vomited, went limp, vomited again. Vomited in ER once.  ICD-9 Codes: 7810 Abnormal involuntary movement, 28866 Bandemia, 4739 Unspecified sinusitis (chronic).
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Clinical narrative: Presented to ER -Died  6/26/09 Autopsy report states COD as SIDS & cause of death as undetermined.  Report also notes visceral congestion; petechiae of lungs; Simian creases of palms; undescended right testis; diaper dermatitis about anus; posterior neck capillary hemangioma; remote subdural hemorrhage.
Age: 0.2
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Unresponsive to stimuli
Clinical narrative: Mom found baby unresponsive 12-23-2004. Went to hospital. 6/22/09 Autopsy report received DOS 12/24/04. Final Cause of Death: Probable encephalitis, Found face down in soft pillow.
Age: 63.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Blood product transfusion, Burning sensation, Guillain-Barre syndrome, Hypoaesthesia, Paraesthesia
Clinical narrative: GBS - numbness, tingling, burning of feet, progressing to calves and near knees. 8 days hospitalization. Immunoglobulin - 5 days.   7/13/09 Hospital records received DOS 12/26/09 to 1/3/09. Assessment: Atypical Guillain Barre Syndrome. Following several days of diarrhea and nausea, the patient presented with bilateral lower extremity weakness and, preceded by numbness, burning sensation and tingling in legs. Several falls injuring knee and twisting ankles. Swelling of right lower extremity. Absent reflexes at ankles, diminished at knees. Intially tachycardic and hypoxic. Left lower lobe pulmonary emboli. Developed progressive weakness and was unable to walk. Septic from urinary tract infection. IVIG.  ICD-9 codes: 357.0, 415.19, 276.1, 401.9, 272.4, 300.00, V12.54, 733.90, 253.8   7/22/09 Received Neuro medical records of 12/2008- FINAL DX: idiopathic polyneuropathy, Guillain Barre syndrome Records reveal patient experienced fever w/thoracic rash, diarrhea, weakness, difficulty walking, several falls w/leg injuries & swelling, excessive sleepiness s/p cruise ship travel.  Initial exam revealed absent ankle reflexes, swollen ankles bilaterally, right calf swelling, ataxia, bilateral weak dorsiflexion & intermittent pain.  Follow up visits s/p hospitalization for AIDP tx w/IVIG reveal patient w/continued leg weakness, bilateral foot drop, s/p PE & on coumadin. Recent fall at home w/burn injury; continuing PT.
Age: 63.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Abasia, Fall, Guillain-Barre syndrome, Hypoaesthesia, Paraesthesia
Clinical narrative: GBS - numbness, tingling, burning of feet, progressing to calves and near knees. 8 days hospitalization. Immunoglobulin - 5 days.   7/13/09 Hospital records received DOS 12/26/09 to 1/3/09. Assessment: Atypical Guillain Barre Syndrome. Following several days of diarrhea and nausea, the patient presented with bilateral lower extremity weakness and, preceded by numbness, burning sensation and tingling in legs. Several falls injuring knee and twisting ankles. Swelling of right lower extremity. Absent reflexes at ankles, diminished at knees. Intially tachycardic and hypoxic. Left lower lobe pulmonary emboli. Developed progressive weakness and was unable to walk. Septic from urinary tract infection. IVIG.  ICD-9 codes: 357.0, 415.19, 276.1, 401.9, 272.4, 300.00, V12.54, 733.90, 253.8   7/22/09 Received Neuro medical records of 12/2008- FINAL DX: idiopathic polyneuropathy, Guillain Barre syndrome Records reveal patient experienced fever w/thoracic rash, diarrhea, weakness, difficulty walking, several falls w/leg injuries & swelling, excessive sleepiness s/p cruise ship travel.  Initial exam revealed absent ankle reflexes, swollen ankles bilaterally, right calf swelling, ataxia, bilateral weak dorsiflexion & intermittent pain.  Follow up visits s/p hospitalization for AIDP tx w/IVIG reveal patient w/continued leg weakness, bilateral foot drop, s/p PE & on coumadin. Recent fall at home w/burn injury; continuing PT.
Age: 26.0
Sex: F
Vaccine: HEP
Symptoms: Pain in extremity
Clinical narrative: i got the hep shot on 4-22-09. it was put in my right arm. still today it still hurts and has pain in it. never had a problem until i got the shot.
Age: 13.0
Sex: F
Vaccine: HPVX
Symptoms: Alopecia, Arthralgia, Headache
Clinical narrative: since having gardasil shots my daughter has complained of frequent headaches, hair loss, and joint pain.
Age: 39.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Tremendous chills and pain in the left arm with swelling and muscle aches. Low grade fever.  Large 4x6" round, raised, indurated, red warm area around the injection site.
Age: 39.0
Sex: F
Vaccine: TDAP
Symptoms: Myalgia, Oedema peripheral, Pain in extremity, Pyrexia
Clinical narrative: Tremendous chills and pain in the left arm with swelling and muscle aches. Low grade fever.  Large 4x6" round, raised, indurated, red warm area around the injection site.
Age: 2.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site pain, Injection site urticaria
Clinical narrative: My son was sore for the remainder of the day after receiving his 2 shots on 6/12/09. He refused to allow me to look, and thinking he was only sore (and maybe a bit of broken pride) didn't fight to look. The following morning while dressing him, I noticed that he had developed hives on the arm around the shot and down to his elbow. While my reported time will be that morning, I suspect it was the evening before, if only I had gotten to see it.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Facial palsy, Headache, Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: Three hours after immunizations patient developed severe headache.  At bedtime patient's mouth was distorted to right and was numb and tingling.  Mouth continued to be drawn to the right through the weekend.  Went to clinic and was diagnosed with Bell's Palsy and treated with methylprednisolone dose pack.  Patient seen at health department on 6/9/09 and reported that the right side of his face still "felt a little weird".  No facial drooping, numbness noted at this time. Patient demonstrated normal facial movements.  Phone call to patient's mother on 6/17/09--mother reports full recovery of her son. Completed steroid dose pack. No complaints of pain, numbness, tingling.
Age: 28.0
Sex: M
Vaccine: HEPAB
Symptoms: Presyncope
Clinical narrative: Patient was administered vaccine. Patient then began to have a vasovagal syncope reaction. Patient was immediately given oxygen. Patient was layed in the prone position with feet elevated and a cold compress a applied to the forehead. Vitals were constatntly monitored. Patient was stable and recovered quickly.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Body temperature increased, Diarrhoea
Clinical narrative: One day after vaccine was given, onset of temperature to 102 axillary and diarrhea. Illness resolved in 3 days total.
Age: 64.0
Sex: M
Vaccine: TDAP
Symptoms: Dyspnoea, Rash, Respiratory tract congestion
Clinical narrative: Inability to breath, extreme shortness of breath.Has never experienced this before. Rash on upper torso. Patient crawled to front door and opened door to cold (frigid temperatures) air, which helped him to breath. Also patient self medicated self with Sudafed and Benadryl.  Still has coldlike congestion in chest.
Age: 14.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Injection site pruritus, Injection site warmth
Clinical narrative: varivax received approx 8 hrslater edema and itching at site. Returned to clinic approx 18 hrs later with 3.5 x 3.5 cm warm, red, indurated itchy rather than tender
Age: 68.0
Sex: M
Vaccine: PPV
Symptoms: Induration, Injection site erythema, Injection site pain, Injection site warmth, Oedema peripheral
Clinical narrative: Fever (104) reduced with acetaminophen, but resumed, red/warm/pain at injection site, arm is swollen and slightly hard/firm to the touch.
Age: 68.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Fever (104) reduced with acetaminophen, but resumed, red/warm/pain at injection site, arm is swollen and slightly hard/firm to the touch.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Anterior interosseous syndrome, Electromyogram abnormal, Hypokinesia, Motor dysfunction, Pain in extremity
Clinical narrative: Dianosis: Left brachial neuritis after HPV/Gardasil vaccinations..History of Illness: 1/20/2009 - Presented for initial evaluation by hand surgeon. By history, patient noticed that her entire left arm was painful 3-4 days after vaccination (Gardasil vac. #2.) Arm pain lasted 24 - 48 hours, then the patient noticed inability to flex the tip of her left thumb. 2/06/2009 - EMG remarkable for left anterior interosseous nerve syndrome. 2/10/2009 -  Patient has no active FPL function and complains of loss of dexterity on the left. 3/10/2009 - No active flexion of her left thumb IP joint. 5/19/2009 - Plan to continue observing her symptoms.  7/27/09 Consultant medical records received DOS 1/20/09 to 5/19/09. Includes neurodiagnostic reports from 12/8/08 and clinical labs from 12/6/08 to 12/26/08. Assessment: Anterior interosseous palsy due to Parsonage Turner syndrome /brachial neuritis.  Patient presented with inability to flex left thumb. Tightness in cubital fossa. Weakness in the hand. Slight weakness in her EDP in her index. Strength is returning.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Radiculitis brachial
Clinical narrative: Dianosis: Left brachial neuritis after HPV/Gardasil vaccinations..History of Illness: 1/20/2009 - Presented for initial evaluation by hand surgeon. By history, patient noticed that her entire left arm was painful 3-4 days after vaccination (Gardasil vac. #2.) Arm pain lasted 24 - 48 hours, then the patient noticed inability to flex the tip of her left thumb. 2/06/2009 - EMG remarkable for left anterior interosseous nerve syndrome. 2/10/2009 -  Patient has no active FPL function and complains of loss of dexterity on the left. 3/10/2009 - No active flexion of her left thumb IP joint. 5/19/2009 - Plan to continue observing her symptoms.  7/27/09 Consultant medical records received DOS 1/20/09 to 5/19/09. Includes neurodiagnostic reports from 12/8/08 and clinical labs from 12/6/08 to 12/26/08. Assessment: Anterior interosseous palsy due to Parsonage Turner syndrome /brachial neuritis.  Patient presented with inability to flex left thumb. Tightness in cubital fossa. Weakness in the hand. Slight weakness in her EDP in her index. Strength is returning.
Age: 10.0
Sex: M
Vaccine: HEPA, TDAP, VARCEL
Symptoms: Dizziness
Clinical narrative: CLIENT GIVEN VACCINES BECAME DIZZY AFTERWARD FEET ELEVATED AND GIVEN COOKIE. DIZZINESS ABATED AFTER FIVE MINUTES.
Age: 14.0
Sex: F
Vaccine: HEP, HPV4, MNQ, TDAP, VARCEL
Symptoms: Bacteraemia, Blood culture positive
Clinical narrative: Patient developed bacteremia without focus and tested positive for Neisseria meningitidis from her blood.  6/24/09 Hospital records received DOS 3/27/09 to 4/3/09. Assessment: Neisseria bacteremia with early sepsis syndrome. Patient presents with maculopapular rash on wrists, palms, soles, and shoulder with fever. Headache, myalgia. Conjunctiva injected.   ICD-9 Codes: 036.9, 782.1, 054.9
Age: 49.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Skin burning sensation, Skin discolouration
Clinical narrative: I received my Zostavax DS PWD #1 ON jANUARY 12, 2009.  I feel fine 95% of the time.  The other 5% my shingles are on fire.  Kind of like a hot poker on my skin.  I got the Shingles vaccine on Jan 12, 2009 on a trip.  Within a week or so I had a little spot of discoloration on my foot.  No pain no bump.  I didn't pay it much attention.  The spot had not changed in a month. The spot remained on my foot, still no pain or bump.  However over the last 4 or 5 weeks the spot became a bump and the bump became several bumps.  I saw my doctor and he put me on the Rx Keflex which didn't really help the spots and bumps. Then this past Sunday June 14,2009, I had different type of spots appear on the same foot.  On June 16, 2009 I had an appointment with my doctor for an unrelated matter and with the new spot pattern he diagnosed me with Shingles.  On June 16, 2009 started on an antiviral medication Valtrex tab 1GM.
Age: 1.08
Sex: M
Vaccine: DTAP, HEPA, MMR, VARCEL
Symptoms: Pyrexia
Clinical narrative: High fever, greater than 103F, axillary. Gave Tylenol and Advil with temp remaining elevated next day when grandparent placed call to vaccine administrator. Advised to have child seen by PCP.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Fall, Loss of consciousness, Tooth fracture
Clinical narrative: Wasnt told to wait immediately after vacine.  Felt ok for a minute or so, got onto the elevator started to feel dizzy and blacked out and face planted into the tile floor out of the elevator. They checked my blood pressure immediately after and took me up to my general doctor for observation and took my blood pressure few more times after.  Broke my 2 front teeth and will be needing dental cosmetic work done.
Age: 52.0
Sex: M
Vaccine: ANTH
Symptoms: Activities of daily living impaired, Arthralgia, Blood calcium normal, Dysstasia, Fatigue
Clinical narrative: Within 1 week of 3rd BIOTHRAX, patient could hardly stand due to the pain in all of his joints and rib cage. He barely got out of bed and could not sleep more than a short while due to the joint pains. He sought evaluation and was given NSAIDS with no improvement. He was tested for RA, which was negative, but he did have an elevated ESR. He had radiologic studies completed that were negative. He also had an MRI that was negative. Around the same time, he noted psoriasis on his scalp, elbows and knees. (He had no previous history of psoriatic lesions, but did have a history of eczema with small patches, usually only on one area of his forearms.) In July 2000, patient was placed on a short steroid burst for an allergic reaction where he broke out in hives. While on the prednisone, his joint pain was completely relieved. He was seen again in late 2000 and polymyalgia rheumatica was suspected, and again, he was placed on Prednisone 30 mg per day. The prednisone was effective in relieving his joint pains, as well as helping to clear his psoriasis.   6/23/09 Medical/Hospital records received DOS 8/16/00 to 9/22/2006. Assessment: Psoriatric arthritis with temporal association to receipt of anthrax vaccine. Patient presented with pain in most joints and rib cage. Fatigue, unable to sleep. Psoriasis - lesions covered 60% of body. Psoriatric arthritis. Hives. Treated with prenisone. Continued low back and L knee pain. Trapezius muscle spasm. Myalgia. Pleurisy, osteopenia, obesity. Hearing diminished.  ICD-9 Code: Psoriatric Arthritis 716.59 Follow-up Information 02-FEB-2007: Psoriatic arthritis. Patient's medical disability evaluation is currently pending.
Age: 52.0
Sex: M
Vaccine: ANTH
Symptoms: Full blood count, Hypersensitivity, Insomnia, Intervertebral disc degeneration, Laboratory test normal
Clinical narrative: Within 1 week of 3rd BIOTHRAX, patient could hardly stand due to the pain in all of his joints and rib cage. He barely got out of bed and could not sleep more than a short while due to the joint pains. He sought evaluation and was given NSAIDS with no improvement. He was tested for RA, which was negative, but he did have an elevated ESR. He had radiologic studies completed that were negative. He also had an MRI that was negative. Around the same time, he noted psoriasis on his scalp, elbows and knees. (He had no previous history of psoriatic lesions, but did have a history of eczema with small patches, usually only on one area of his forearms.) In July 2000, patient was placed on a short steroid burst for an allergic reaction where he broke out in hives. While on the prednisone, his joint pain was completely relieved. He was seen again in late 2000 and polymyalgia rheumatica was suspected, and again, he was placed on Prednisone 30 mg per day. The prednisone was effective in relieving his joint pains, as well as helping to clear his psoriasis.   6/23/09 Medical/Hospital records received DOS 8/16/00 to 9/22/2006. Assessment: Psoriatric arthritis with temporal association to receipt of anthrax vaccine. Patient presented with pain in most joints and rib cage. Fatigue, unable to sleep. Psoriasis - lesions covered 60% of body. Psoriatric arthritis. Hives. Treated with prenisone. Continued low back and L knee pain. Trapezius muscle spasm. Myalgia. Pleurisy, osteopenia, obesity. Hearing diminished.  ICD-9 Code: Psoriatric Arthritis 716.59 Follow-up Information 02-FEB-2007: Psoriatic arthritis. Patient's medical disability evaluation is currently pending.
Age: 52.0
Sex: M
Vaccine: ANTH
Symptoms: Muscle spasms, Musculoskeletal chest pain, Nuclear magnetic resonance imaging normal, Polymyalgia rheumatica, Psoriasis
Clinical narrative: Within 1 week of 3rd BIOTHRAX, patient could hardly stand due to the pain in all of his joints and rib cage. He barely got out of bed and could not sleep more than a short while due to the joint pains. He sought evaluation and was given NSAIDS with no improvement. He was tested for RA, which was negative, but he did have an elevated ESR. He had radiologic studies completed that were negative. He also had an MRI that was negative. Around the same time, he noted psoriasis on his scalp, elbows and knees. (He had no previous history of psoriatic lesions, but did have a history of eczema with small patches, usually only on one area of his forearms.) In July 2000, patient was placed on a short steroid burst for an allergic reaction where he broke out in hives. While on the prednisone, his joint pain was completely relieved. He was seen again in late 2000 and polymyalgia rheumatica was suspected, and again, he was placed on Prednisone 30 mg per day. The prednisone was effective in relieving his joint pains, as well as helping to clear his psoriasis.   6/23/09 Medical/Hospital records received DOS 8/16/00 to 9/22/2006. Assessment: Psoriatric arthritis with temporal association to receipt of anthrax vaccine. Patient presented with pain in most joints and rib cage. Fatigue, unable to sleep. Psoriasis - lesions covered 60% of body. Psoriatric arthritis. Hives. Treated with prenisone. Continued low back and L knee pain. Trapezius muscle spasm. Myalgia. Pleurisy, osteopenia, obesity. Hearing diminished.  ICD-9 Code: Psoriatric Arthritis 716.59 Follow-up Information 02-FEB-2007: Psoriatic arthritis. Patient's medical disability evaluation is currently pending.
Age: 52.0
Sex: M
Vaccine: ANTH
Symptoms: Red blood cell sedimentation rate increased, Rheumatoid factor negative, Sleep disorder, Urticaria, X-ray abnormal
Clinical narrative: Within 1 week of 3rd BIOTHRAX, patient could hardly stand due to the pain in all of his joints and rib cage. He barely got out of bed and could not sleep more than a short while due to the joint pains. He sought evaluation and was given NSAIDS with no improvement. He was tested for RA, which was negative, but he did have an elevated ESR. He had radiologic studies completed that were negative. He also had an MRI that was negative. Around the same time, he noted psoriasis on his scalp, elbows and knees. (He had no previous history of psoriatic lesions, but did have a history of eczema with small patches, usually only on one area of his forearms.) In July 2000, patient was placed on a short steroid burst for an allergic reaction where he broke out in hives. While on the prednisone, his joint pain was completely relieved. He was seen again in late 2000 and polymyalgia rheumatica was suspected, and again, he was placed on Prednisone 30 mg per day. The prednisone was effective in relieving his joint pains, as well as helping to clear his psoriasis.   6/23/09 Medical/Hospital records received DOS 8/16/00 to 9/22/2006. Assessment: Psoriatric arthritis with temporal association to receipt of anthrax vaccine. Patient presented with pain in most joints and rib cage. Fatigue, unable to sleep. Psoriasis - lesions covered 60% of body. Psoriatric arthritis. Hives. Treated with prenisone. Continued low back and L knee pain. Trapezius muscle spasm. Myalgia. Pleurisy, osteopenia, obesity. Hearing diminished.  ICD-9 Code: Psoriatric Arthritis 716.59 Follow-up Information 02-FEB-2007: Psoriatic arthritis. Patient's medical disability evaluation is currently pending.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Cognitive disorder, Computerised tomogram normal, Disturbance in attention, Fatigue
Clinical narrative: Description: Had febrile illness within 24 hours for both vaccines.  1st episode required hospitalization.  Developed chronic headaches after 2000 dose and also chronic fatigue, arthralgias.  This developed into full CFS that has persisted to the present.  See full summary.  Symptom:  Joint Pain, multiple joints.  Symptom:  Headache, general.  Symptom:  Insomnia.  Symptom:  Fatigue.  Symptom:  Cognitive deficiency.  Symptom:  Neuropathy.  08/24/09 Received medical  & vaccine records. FINAL DX: chronic fatigue syndrome Records reveal patient experienced the following after the initial anthrax vaccine & aggravation of symptoms after subsequent vaccinations: alterations in memory, difficulty concentrating, muscle cramps, joint pain, chronic fatigue, paresthesias of left arm/leg, sleep disturbance, decreased sexual drive, erectile dysfunction, intermittent blurred vision, migraine HA, intermittent tinnitus, alternating constipation & diarrhea, pulmonary nodules, chronic rhinitis, C6 radiculopathy, chills, night sweats, extreme fatigue, . Multiple consults done. Follow-up: Was still symptomatic as of December 08 but have lost contact now.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Headache, Headache, Insomnia, Libido decreased, Memory impairment
Clinical narrative: Description: Had febrile illness within 24 hours for both vaccines.  1st episode required hospitalization.  Developed chronic headaches after 2000 dose and also chronic fatigue, arthralgias.  This developed into full CFS that has persisted to the present.  See full summary.  Symptom:  Joint Pain, multiple joints.  Symptom:  Headache, general.  Symptom:  Insomnia.  Symptom:  Fatigue.  Symptom:  Cognitive deficiency.  Symptom:  Neuropathy.  08/24/09 Received medical  & vaccine records. FINAL DX: chronic fatigue syndrome Records reveal patient experienced the following after the initial anthrax vaccine & aggravation of symptoms after subsequent vaccinations: alterations in memory, difficulty concentrating, muscle cramps, joint pain, chronic fatigue, paresthesias of left arm/leg, sleep disturbance, decreased sexual drive, erectile dysfunction, intermittent blurred vision, migraine HA, intermittent tinnitus, alternating constipation & diarrhea, pulmonary nodules, chronic rhinitis, C6 radiculopathy, chills, night sweats, extreme fatigue, . Multiple consults done. Follow-up: Was still symptomatic as of December 08 but have lost contact now.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Neuropathy peripheral, Night sweats, Nodule, Nuclear magnetic resonance imaging abnormal, Pyrexia
Clinical narrative: Description: Had febrile illness within 24 hours for both vaccines.  1st episode required hospitalization.  Developed chronic headaches after 2000 dose and also chronic fatigue, arthralgias.  This developed into full CFS that has persisted to the present.  See full summary.  Symptom:  Joint Pain, multiple joints.  Symptom:  Headache, general.  Symptom:  Insomnia.  Symptom:  Fatigue.  Symptom:  Cognitive deficiency.  Symptom:  Neuropathy.  08/24/09 Received medical  & vaccine records. FINAL DX: chronic fatigue syndrome Records reveal patient experienced the following after the initial anthrax vaccine & aggravation of symptoms after subsequent vaccinations: alterations in memory, difficulty concentrating, muscle cramps, joint pain, chronic fatigue, paresthesias of left arm/leg, sleep disturbance, decreased sexual drive, erectile dysfunction, intermittent blurred vision, migraine HA, intermittent tinnitus, alternating constipation & diarrhea, pulmonary nodules, chronic rhinitis, C6 radiculopathy, chills, night sweats, extreme fatigue, . Multiple consults done. Follow-up: Was still symptomatic as of December 08 but have lost contact now.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Radiculopathy, Ultrasound scan normal
Clinical narrative: Description: Had febrile illness within 24 hours for both vaccines.  1st episode required hospitalization.  Developed chronic headaches after 2000 dose and also chronic fatigue, arthralgias.  This developed into full CFS that has persisted to the present.  See full summary.  Symptom:  Joint Pain, multiple joints.  Symptom:  Headache, general.  Symptom:  Insomnia.  Symptom:  Fatigue.  Symptom:  Cognitive deficiency.  Symptom:  Neuropathy.  08/24/09 Received medical  & vaccine records. FINAL DX: chronic fatigue syndrome Records reveal patient experienced the following after the initial anthrax vaccine & aggravation of symptoms after subsequent vaccinations: alterations in memory, difficulty concentrating, muscle cramps, joint pain, chronic fatigue, paresthesias of left arm/leg, sleep disturbance, decreased sexual drive, erectile dysfunction, intermittent blurred vision, migraine HA, intermittent tinnitus, alternating constipation & diarrhea, pulmonary nodules, chronic rhinitis, C6 radiculopathy, chills, night sweats, extreme fatigue, . Multiple consults done. Follow-up: Was still symptomatic as of December 08 but have lost contact now.
Age: 35.0
Sex: U
Vaccine: ANTH, YF
Symptoms: Antinuclear antibody negative, Arthralgia, Blood thyroid stimulating hormone normal, Full blood count normal, Metabolic function test
Clinical narrative: Description: Diffuse maculopapular rash of both UE/LE and trunk within 48 hours of anthrax #2 and yellow fever vaccines.  Symptom:  Joint Pain, multiple joints Start: 11/04/1997 Comment: bilateral hands, feet, knees.  Symptom:  Rash, pruritic Start:  06/30/1996 Symptom:  Rash, diffuse Start:  06/30/1996